Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 157

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Enhanced Stem Cell Differentiation and Immunopurification of Genome Engineered Human Retinal Ganglion Cells

Sluch, Valentin M., Chamling, Xitiz, Liu, Melissa M., Berlinicke, Cynthia A., Cheng, Jie, Mitchell, Katherine L., Welsbie, Derek S., Zack, Donald J. · 2017 · Stem Cells Translational Medicine

Abstract

Human pluripotent stem cells have the potential to promote biological studies and accelerate drug discovery efforts by making possible direct experimentation on a variety of human cell types of interest. However, stem cell cultures are generally heterogeneous and efficient differentiation and purification protocols are often lacking. Here, we describe the generation of clustered regularly-interspaced short palindromic repeats(CRISPR)-Cas9 engineered reporter knock-in embryonic stem cell lines in which tdTomato and a unique cell-surface protein, THY1.2, are expressed under the control of the retinal ganglion cell (RGC)-enriched gene BRN3B. Using these reporter cell lines, we greatly improved adherent stem cell differentiation to the RGC lineage by optimizing a novel combination of small molecules and established an anti-THY1.2-based protocol that allows for large-scale RGC immunopurification. RNA-sequencing confirmed the similarity of the stem cell-derived RGCs to their endogenous human counterparts. Additionally, we developed an in vitro axonal injury model suitable for studying signaling pathways and mechanisms of human RGC cell death and for high-throughput screening for neuroprotective compounds. Using this system in combination with RNAi-based knockdown, we show that knockdown of dual leucine kinase (DLK) promotes survival of human RGCs, expanding to the human system prior reports that DLK inhibition is neuroprotective for murine RGCs. These improvements will facilitate the development and use of large-scale experimental paradigms that require numbers of pure RGCs that were not previously obtainable.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/sctm.17-0059

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 62

  1. Kingman, 2004, Glaucoma is second leading cause of blindness globally, Bull World Health Org, 82, 887
  2. Sluch, 2014, Stem cells, retinal ganglion cells and glaucoma, Dev Ophthalmol, 53, 111, 10.1159/000358409 · DOI
  3. Fernandes, 2015, Using genetic mouse models to gain insight into glaucoma: Past results and future possibilities, 42
  4. Levin, 2002, Retinal ganglion cell disorders: Types and treatments, Prog Retin Eye Res, 21, 465, 10.1016/S1350-9462(02)00012-5 · DOI
  5. Welsbie, 2013, Functional genomic screening identifies dual leucine zipper kinase as a key mediator of retinal ganglion cell death, Proc Natl Acad Sci USA, 110, 4045, 10.1073/pnas.1211284110 · DOI · Paper page
  6. Sandoe, 2013, Opportunities and challenges of pluripotent stem cell neurodegenerative disease models, Nat Neurosci, 16, 780, 10.1038/nn.3425 · DOI · Paper page
  7. Mertens, 2013, APP processing in human pluripotent stem cell-derived neurons is resistant to NSAID-based gamma-secretase modulation, Stem Cell Reports, 1, 491, 10.1016/j.stemcr.2013.10.011 · DOI
  8. Tanaka, 2015, Generation of retinal ganglion cells with functional axons from human induced pluripotent stem cells, Sci Rep, 5, 8344, 10.1038/srep08344 · DOI
  9. Meyer, 2011, Optic vesicle-like structures derived from human pluripotent stem cells facilitate a customized approach to retinal disease treatment, Stem Cells, 29, 1206, 10.1002/stem.674 · DOI · Paper page
  10. Sluch, 2015, Differentiation of human ESCs to retinal ganglion cells using a CRISPR engineered reporter cell line, Sci Rep, 5, 16595, 10.1038/srep16595 · DOI
  11. Gill, 2016, Enriched retinal ganglion cells derived from human embryonic stem cells, Sci Rep, 6, 30552, 10.1038/srep30552 · DOI
  12. Maruotti, 2013, A simple and scalable process for the differentiation of retinal pigment epithelium from human pluripotent stem cells, Stem Cells Translational Medicine, 2, 341, 10.5966/sctm.2012-0106 · DOI
  13. Kim, 2015, HISAT: A fast spliced aligner with low memory requirements, Nat Methods, 12, 357, 10.1038/nmeth.3317 · DOI · Paper page
  14. Trapnell, 2010, Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation, Nat Biotechnol, 28, 511, 10.1038/nbt.1621 · DOI · Paper page
  15. Barres, 1988, Immunological, morphological, and electrophysiological variation among retinal ganglion cells purified by panning, Neuron, 1, 791, 10.1016/0896-6273(88)90127-4 · DOI · Paper page
  16. Koumas, 2003, Thy-1 expression in human fibroblast subsets defines myofibroblastic or lipofibroblastic phenotypes, Am J Pathol, 163, 1291, 10.1016/S0002-9440(10)63488-8 · DOI · Paper page
  17. Day, 2009, The fluorescent protein palette: Tools for cellular imaging, Chem Soc Rev, 38, 2887, 10.1039/b901966a · DOI · Paper page
  18. Miltenyi, 1990, High gradient magnetic cell separation with MACS, Cytometry, 11, 231, 10.1002/cyto.990110203 · DOI · Paper page
  19. Grutzkau, 2010, Small but mighty: How the MACS-technology based on nanosized superparamagnetic particles has helped to analyze the immune system within the last 20 years, Cytometry A, 77, 643, 10.1002/cyto.a.20918 · DOI
  20. Maroof, 2013, Directed differentiation and functional maturation of cortical interneurons from human embryonic stem cells, Cell Stem Cell, 12, 559, 10.1016/j.stem.2013.04.008 · DOI · Paper page
  21. Shen, 2007, Nodal signaling: Developmental roles and regulation, Development, 134, 1023, 10.1242/dev.000166 · DOI · Paper page
  22. Borowiak, 2009, Small molecules efficiently direct endodermal differentiation of mouse and human embryonic stem cells, Cell Stem Cell, 4, 348, 10.1016/j.stem.2009.01.014 · DOI · Paper page
  23. Maruotti, 2015, Small-molecule-directed, efficient generation of retinal pigment epithelium from human pluripotent stem cells, Proc Natl Acad Sci USA, 112, 10950, 10.1073/pnas.1422818112 · DOI
  24. Griffin, 2013, Nicotinamide promotes neuronal differentiation of mouse embryonic stem cells in vitro, Neuroreport, 24, 1041, 10.1097/WNR.0000000000000071 · DOI
  25. Villa-Diaz, 2013, Concise review: The evolution of human pluripotent stem cell culture: From feeder cells to synthetic coatings, Stem Cells, 31, 1, 10.1002/stem.1260 · DOI · Paper page
  26. Pennington, 2015, Defined culture of human embryonic stem cells and xeno-free derivation of retinal pigmented epithelial cells on a novel, synthetic substrate, Stem Cells Translational Medicine, 4, 165, 10.5966/sctm.2014-0179 · DOI
  27. Baranov, 2013, Synthetic peptide-acrylate surface for self-renewal of human retinal progenitor cells, Tissue Eng Part C Methods, 19, 265, 10.1089/ten.tec.2012.0217 · DOI
  28. Jin, 2012, A synthetic, xeno-free peptide surface for expansion and directed differentiation of human induced pluripotent stem cells, PLoS One, 7, e50880, 10.1371/journal.pone.0050880 · DOI
  29. Nelson, 2006, Notch activity is downregulated just prior to retinal ganglion cell differentiation, Dev Neurosci, 28, 128, 10.1159/000090759 · DOI
  30. Xie, 2014, Differentiation of retinal ganglion cells and photoreceptor precursors from mouse induced pluripotent stem cells carrying an Atoh7/Math5 lineage reporter, PLoS One, 9, e112175, 10.1371/journal.pone.0112175 · DOI
  31. Riazifar, 2014, Chemically induced specification of retinal ganglion cells from human embryonic and induced pluripotent stem cells, Stem Cells Translational Medicine, 3, 424, 10.5966/sctm.2013-0147 · DOI
  32. Kim, 2006, Gene expression profile of the adult human retinal ganglion cell layer, Mol Vis, 12, 1640
  33. Storey, 2003, Statistical significance for genomewide studies, Proc Natl Acad Sci USA, 100, 9440, 10.1073/pnas.1530509100 · DOI · Paper page
  34. Levin, 2008, History of neuroprotection and rationale as a therapy for glaucoma, Am J Manag Care, 14, S11
  35. Tian, 2015, Current perspective of neuroprotection and glaucoma, Clin Ophthalmol, 9, 2109
  36. Welsbie, 2017, Enhanced functional genomic screening identifies novel mediators of dual leucine zipper kinase-dependent injury signaling in neurons, Neuron, 94, 1142, 10.1016/j.neuron.2017.06.008 · DOI · Paper page
  37. Bounoutas, 2011, Microtubule depolymerization in Caenorhabditis elegans touch receptor neurons reduces gene expression through a p38 MAPK pathway, Proc Natl Acad Sci, 108, 3982, 10.1073/pnas.1101360108 · DOI
  38. Valakh, 2015, Cytoskeletal disruption activates the DLK/JNK pathway, which promotes axonal regeneration and mimics a preconditioning injury, Neurobiol Dis, 77, 13, 10.1016/j.nbd.2015.02.014 · DOI
  39. Aquino, 2006, Nerve degeneration is prevented by a single intraneural apotransferrin injection into colchicine-injured sciatic nerves in the rat, Brain Res, 1117, 80, 10.1016/j.brainres.2006.02.045 · DOI
  40. Hannus, 1984, siPools: Highly complex but accurately defined siRNA pools eliminate off-target effects, Nucleic Acids Res, 42, 8049, 10.1093/nar/gku480 · DOI · Paper page
  41. Zhang, 2012, Ophthalmic drug discovery: Novel targets and mechanisms for retinal diseases and glaucoma, Nat Rev Drug Discov, 11, 541, 10.1038/nrd3745 · DOI · Paper page
  42. Meyer, 2009, Modeling early retinal development with human embryonic and induced pluripotent stem cells, Proc Natl Acad Sci USA, 106, 16698, 10.1073/pnas.0905245106 · DOI · Paper page
  43. Osakada, 2008, Toward the generation of rod and cone photoreceptors from mouse, monkey and human embryonic stem cells, Nat Biotechnol, 26, 215, 10.1038/nbt1384 · DOI · Paper page
  44. Williams, 1996, Genetic and environmental control of variation in retinal ganglion cell number in mice, J Neurosci, 16, 7193, 10.1523/JNEUROSCI.16-22-07193.1996 · DOI · Paper page
  45. Patani, 2009, Activin/Nodal inhibition alone accelerates highly efficient neural conversion from human embryonic stem cells and imposes a caudal positional identity, PLoS One, 4, e7327, 10.1371/journal.pone.0007327 · DOI
  46. Nomura, 1998, Smad2 role in mesoderm formation, left-right patterning and craniofacial development, Nature, 393, 786, 10.1038/31693 · DOI · Paper page
  47. Take-uchi, 2003, Hedgehog signalling maintains the optic stalk-retinal interface through the regulation of Vax gene activity, Development, 130, 955, 10.1242/dev.00305 · DOI · Paper page
  48. Masai, 2000, Midline signals regulate retinal neurogenesis in zebrafish, Neuron, 27, 251, 10.1016/S0896-6273(00)00034-9 · DOI · Paper page
  49. Wang, 2001, Requirement for math5 in the development of retinal ganglion cells, Genes Dev, 15, 24, 10.1101/gad.855301 · DOI · Paper page
  50. Brown, 2001, Math5 is required for retinal ganglion cell and optic nerve formation, Development, 128, 2497, 10.1242/dev.128.13.2497 · DOI · Paper page
  51. Lupo, 2013, Multiple roles of Activin/Nodal, bone morphogenetic protein, fibroblast growth factor and Wnt/beta-catenin signalling in the anterior neural patterning of adherent human embryonic stem cell cultures, Open Biol, 3, 120167, 10.1098/rsob.120167 · DOI
  52. Bertacchi, 2015, Activin/Nodal Signaling supports retinal progenitor specification in a narrow time window during pluripotent stem cell neuralization, Stem Cell Reports, 5, 532, 10.1016/j.stemcr.2015.08.011 · DOI
  53. Westenskow, 2015, Efficient derivation of retinal pigment epithelium cells from stem cells, J Vis Exp, 10.3791/52214 · DOI
  54. Sanvitale, 2013, A new class of small molecule inhibitor of BMP signaling, PLoS One, 8, e62721, 10.1371/journal.pone.0062721 · DOI · Paper page
  55. Bayramov, 2011, Novel functions of Noggin proteins: Inhibition of Activin/Nodal and Wnt signaling, Development, 138, 5345, 10.1242/dev.068908 · DOI
  56. Kuwahara, 2015, Generation of a ciliary margin-like stem cell niche from self-organizing human retinal tissue, Nat Commun, 6, 6286, 10.1038/ncomms7286 · DOI · Paper page
  57. Du, 2010, Regulation of retinal progenitor cell differentiation by bone morphogenetic protein 4 is mediated by the smad/id cascade, Invest Ophthalmol Vis Sci, 51, 3764, 10.1167/iovs.09-4906 · DOI
  58. Venugopalan, 2016, Transplanted neurons integrate into adult retinas and respond to light, Nat Commun, 7, 10472, 10.1038/ncomms10472 · DOI · Paper page
  59. Chamling, 2016, The potential of human stem cells for the study and treatment of glaucoma, Invest Ophthalmol Vis Sci, 57, ORSFi1, 10.1167/iovs.15-18590 · DOI
  60. Badea, 2012, Combinatorial expression of Brn3 transcription factors in somatosensory neurons: Genetic and morphologic analysis, J Neurosci, 32, 995, 10.1523/JNEUROSCI.4755-11.2012 · DOI
  61. Badea, 2009, Distinct roles of transcription factors brn3a and brn3b in controlling the development, morphology, and function of retinal ganglion cells, Neuron, 61, 852, 10.1016/j.neuron.2009.01.020 · DOI · Paper page
  62. Schmidt, 2011, Intrinsically photosensitive retinal ganglion cells: Many subtypes, diverse functions, Trends Neurosci, 34, 572, 10.1016/j.tins.2011.07.001 · DOI · Paper page

Cited by

See all 157

Metadata

Authors
Sluch, V. M., Chamling, X., Liu, M. M., Berlinicke, C. A., Cheng, J., Mitchell, K. L., Welsbie, D. S., & Zack, D. J.
Venue
Stem Cells Translational Medicine
Published
2017-10-10
Volume
6
Issue
11
Pages
1972-1986
ISSN
  • 2157-6564
  • 2157-6580
Cited by
157
References
16
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.